Refana

News

  • Home
  • Programs
    • AI in Medicine
    • Vaccines
    • Early Cancer Detection
  • Corporate
  • Team
  • About
  • Blog
    • News
    • COVID Industry Updates

1/11/2021

[ANALYSIS] The Chinese COVID-19 vaccines, Sinopharm and Sinovac, are effective

0 Comments

Read Now
 
Picture

'There are two significant advantages with these inactivated vaccines that should greatly impact our vaccine distribution program in the Philippines'


Over the past two months, we have learned that 3 COVID-19 vaccines developed in the West have successfully passed their Phase 3 clinical trials. Both of the vaccines from Moderna and Pfizer had an efficacy of around 95%, while the vaccine from AstraZeneca (AZ) had an efficacy of 62% with the standard dosing schedule that received an emergency authorization in the United Kingdom. 

We have now learned that the two Chinese vaccines developed by Sinopharm and Sinovac have also passed their Phase 3 clinical trials, with an efficacy of 79% and 78%, respectively. However, details from these trials still remain unpublished at this time. (READ: China's Sinopharm says vaccine 79% effective vs coronavirus)

The two vaccines developed in China belong to a new class of COVID-19 vaccines. Both are vaccines incorporating inactivated viruses, where the intact SARS-CoV2 virus that causes COVID-19 is killed and mixed with chemicals that stimulate an immune response. The Sinopharm vaccine was tested in 60,000 volunteers from 125 countries, while the Sinovac vaccine was trialed with 12,476 individuals from Brazil. Both vaccines prevented participants from developing severe disease with complications that would hospitalize them. There were no severe side effects with either vaccine.

​There are two significant advantages with these inactivated vaccines that should greatly impact our vaccine distribution program in the Philippines.  

First, these vaccines can be stored in a standard refrigerator at temperatures of 2 to 8 degrees Celsius, and can remain stable for up to 3 years. This would make distribution of these vaccines in the Philippines substantially cheaper and easier as compared to the Pfizer and Moderna vaccines, which require a supercold or an ultracold chain with freezers at temperatures of -70 to -80 degrees Celsius. 

Second, in principle, these inactivated vaccines should be more resilient and should be more effective against any and all SARS-CoV2 variants than the Western vaccines. Why? The Pfizer, Moderna, and AZ vaccines are composed of one part of the virus called the Spike protein. The most significant mutations in the SARS-CoV2 variants change this Spike protein, making these variants more able to escape the Western vaccines. Just a few days ago, there was a worrisome report that the South African 501.V2 variant lowers the effectiveness of antibody-based drugs against COVID-19, suggesting that this variant will lower the efficacy of the Western COVID-19 vaccines.

In contrast, these Chinese vaccines introduce the entire inactivated virus into vaccinated individuals. Novel virus variants of SARS-CoV2 would have to change everything about themselves to escape these inactivated vaccines. The probability of this happening is vanishingly small. Therefore, these vaccines would be valuable weapons against COVID-19, especially in light of the growing concerns with the B117 variant from England and the 501.V2 variant from South Africa.

Read the full article.

NICANOR AUSTRIACO OP

Reverend Fr. Nicanor Austriaco is Visiting Professor of Biological Sciences at the University of Santo Tomas, and an OCTA Research Fellow.
​
Back to Blog

Share

0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

Details

    Categories

    All
    Artificial Intelligence
    Blood Testing
    Covid 19
    Early Cancer Detection
    Press Release

    Archives

    January 2023
    November 2022
    September 2022
    July 2022
    May 2022
    April 2022
    March 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    July 2020
    June 2020

    RSS Feed

​Practical Solutions for complex and ​urgent global medical problems

HOME     |     PROGRAMS    |    TEAM     |     ABOUT     |     NEWS
Privacy Policy | Cookie Policy
© 2023 Refana Inc
  • Home
  • Programs
    • AI in Medicine
    • Vaccines
    • Early Cancer Detection
  • Corporate
  • Team
  • About
  • Blog
    • News
    • COVID Industry Updates